These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Clinical features of anti-synthetase syndrome associated interstitial lung disease: a retrospective cohort in China. Zhan X; Yan W; Wang Y; Li Q; Shi X; Gao Y; Ye Q BMC Pulm Med; 2021 Feb; 21(1):57. PubMed ID: 33579248 [TBL] [Abstract][Full Text] [Related]
6. Analysis of the clinical features of antisynthetase syndrome: a retrospective cohort study in China. Wang R; Zhao Y; Qi F; Wu X; Wang Y; Xu Y; Wu Y; Zhang N; Hou H; Sun W; Li X; Wei W Clin Rheumatol; 2023 Mar; 42(3):703-709. PubMed ID: 36308573 [TBL] [Abstract][Full Text] [Related]
7. Clinical manifestations and long-term outcome of anti-Jo1 antisynthetase patients in a large cohort of Spanish patients from the GEAS-IIM group. Trallero-Araguás E; Grau-Junyent JM; Labirua-Iturburu A; García-Hernández FJ; Monteagudo-Jiménez M; Fraile-Rodriguez G; Les-Bujanda I; Rodriguez-Carballeira M; Sáez-Comet L; Selva-O'Callaghan A; Semin Arthritis Rheum; 2016 Oct; 46(2):225-231. PubMed ID: 27139168 [TBL] [Abstract][Full Text] [Related]
11. Clinical and prognostic associations of anti-Jo-1 antibody levels in patients with antisynthetase syndrome. Yang H; Chen Q; Sun C; Jin Q; Zhang L; Liu Q; Peng Q; Wang G; Lu X Respir Res; 2024 May; 25(1):222. PubMed ID: 38811943 [TBL] [Abstract][Full Text] [Related]
13. Anti-Jo-1 Syndrome Often Misdiagnosed as Rheumatoid Arthritis (for Many Years): A Single-Center Experience. Kumar RR; Jha S; Dhooria A; Naidu GSRSNK; Minz RW; Kumar S; Sharma SK; Sharma A; Jain S; Dhir V J Clin Rheumatol; 2021 Jun; 27(4):150-155. PubMed ID: 31895110 [TBL] [Abstract][Full Text] [Related]
14. Interstitial lung disease in anti-Jo-1 patients with antisynthetase syndrome. Marie I; Josse S; Hatron PY; Dominique S; Hachulla E; Janvresse A; Cherin P; Mouthon L; Vittecoq O; Menard JF; Jouen F Arthritis Care Res (Hoboken); 2013 May; 65(5):800-8. PubMed ID: 23203765 [TBL] [Abstract][Full Text] [Related]
15. Clinical characterisation of a multicentre nationwide cohort of patients with antisynthetase syndrome. Martins P; Dourado E; Melo AT; Samões B; Sousa M; Freitas R; Lourenço MH; Fernandes B; Costa E; Parente H; Martins F; Fonseca JE; Cordeiro I; Romão VC; Khmelinskii N; Campanilho-Marques R ARP Rheumatol; 2022 Nov; 1(ARP Rheumatology, nº3 2022):190-196. PubMed ID: 35891592 [TBL] [Abstract][Full Text] [Related]
16. Clinical features and outcomes of interstitial lung disease in anti-Jo-1 positive antisynthetase syndrome. Zamora AC; Hoskote SS; Abascal-Bolado B; White D; Cox CW; Ryu JH; Moua T Respir Med; 2016 Sep; 118():39-45. PubMed ID: 27578469 [TBL] [Abstract][Full Text] [Related]
17. Myositis-related interstitial lung disease and antisynthetase syndrome. Solomon J; Swigris JJ; Brown KK J Bras Pneumol; 2011; 37(1):100-9. PubMed ID: 21390438 [TBL] [Abstract][Full Text] [Related]
18. Anti-PL-7 (anti-threonyl-tRNA synthetase) antisynthetase syndrome: clinical manifestations in a series of patients from a European multicenter study (EUMYONET) and review of the literature. Labirua-Iturburu A; Selva-O'Callaghan A; Vincze M; Dankó K; Vencovsky J; Fisher B; Charles P; Dastmalchi M; Lundberg IE Medicine (Baltimore); 2012 Jul; 91(4):206-211. PubMed ID: 22732951 [TBL] [Abstract][Full Text] [Related]